These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12161113)

  • 41. 5beta-reduced neuroactive steroids are novel voltage-dependent blockers of T-type Ca2+ channels in rat sensory neurons in vitro and potent peripheral analgesics in vivo.
    Todorovic SM; Pathirathna S; Brimelow BC; Jagodic MM; Ko SH; Jiang X; Nilsson KR; Zorumski CF; Covey DF; Jevtovic-Todorovic V
    Mol Pharmacol; 2004 Nov; 66(5):1223-35. PubMed ID: 15280444
    [TBL] [Abstract][Full Text] [Related]  

  • 42. (S)-4-Methyl-2-(methylamino)pentanoic acid [4, 4-bis(4-fluorophenyl)butyl]amide hydrochloride, a novel calcium channel antagonist, is efficacious in several animal models of pain.
    Song Y; Bowersox SS; Connor DT; Dooley DJ; Lotarski SM; Malone T; Miljanich G; Millerman E; Rafferty MF; Rock D; Roth BD; Schmidt J; Stoehr S; Szoke BG; Taylor C; Vartanian M; Wang YX
    J Med Chem; 2000 Sep; 43(19):3474-7. PubMed ID: 11000000
    [No Abstract]   [Full Text] [Related]  

  • 43. Spinal antinociception of synthetic omega-conotoxin SO-3, a selective N-type neuronal voltage-sensitive calcium channel blocker, and its effects on morphine analgesia in chemical stimulus tests in rodent.
    Yan LD; Liu YL; Zhang L; Dong HJ; Zhou PL; Su RB; Gong ZH; Huang PT
    Eur J Pharmacol; 2010 Jun; 636(1-3):73-81. PubMed ID: 20361956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain.
    Bowersox SS; Gadbois T; Singh T; Pettus M; Wang YX; Luther RR
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1243-9. PubMed ID: 8968347
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and biological evaluation of nonpeptide mimetics of omega-conotoxin GVIA.
    Baell JB; Duggan PJ; Forsyth SA; Lewis RJ; Lok YP; Schroeder CI
    Bioorg Med Chem; 2004 Aug; 12(15):4025-37. PubMed ID: 15246080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats.
    Jarvis MF; Scott VE; McGaraughty S; Chu KL; Xu J; Niforatos W; Milicic I; Joshi S; Zhang Q; Xia Z
    Biochem Pharmacol; 2014 Jun; 89(4):536-44. PubMed ID: 24726441
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and biological evaluation of 4-piperidinecarboxylate and 4-piperidinecyanide derivatives for T-type calcium channel blockers.
    Woo HM; Lee YS; Roh EJ; Seo SH; Song CM; Chung HJ; Pae AN; Shin KJ
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5910-5. PubMed ID: 21843937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evolving therapeutic indications for N-type calcium channel blockers: from chronic pain to alcohol abuse.
    Belardetti F
    Future Med Chem; 2010 May; 2(5):791-802. PubMed ID: 21426203
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-throughput screening for N-type calcium channel blockers using a scintillation proximity assay.
    Zhang SP; Kauffman J; Yagel SK; Codd EE
    J Biomol Screen; 2006 Sep; 11(6):672-7. PubMed ID: 16831862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of mirogabalin, a novel ligand for the α₂δ subunit of voltage-gated calcium channels, on N-type calcium channel currents of rat dorsal root ganglion culture neurons.
    Kitano Y; Wakimoto S; Tamura S; Kubota K; Domon Y; Arakawa N; Saito M; Sava B; Buisson B
    Pharmazie; 2019 Mar; 74(3):147-149. PubMed ID: 30961679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure-Activity Studies Reveal the Molecular Basis for GABA
    Sadeghi M; Carstens BB; Callaghan BP; Daniel JT; Tae HS; O'Donnell T; Castro J; Brierley SM; Adams DJ; Craik DJ; Clark RJ
    ACS Chem Biol; 2018 Jun; 13(6):1577-1587. PubMed ID: 29746088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analgesic (omega)-conotoxins CVIE and CVIF selectively and voltage-dependently block recombinant and native N-type calcium channels.
    Berecki G; Motin L; Haythornthwaite A; Vink S; Bansal P; Drinkwater R; Wang CI; Moretta M; Lewis RJ; Alewood PF; Christie MJ; Adams DJ
    Mol Pharmacol; 2010 Feb; 77(2):139-48. PubMed ID: 19892914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of subcutaneous administration of calcium channel blockers on nerve injury-induced hyperalgesia.
    White DM; Cousins MJ
    Brain Res; 1998 Aug; 801(1-2):50-8. PubMed ID: 9729273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of intrathecal administration of ziconotide, a selective neuronal N-type calcium channel blocker, on mechanical allodynia and heat hyperalgesia in a rat model of postoperative pain.
    Wang YX; Pettus M; Gao D; Phillips C; Scott Bowersox S
    Pain; 2000 Feb; 84(2-3):151-8. PubMed ID: 10666519
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of diphenyl lactam derivatives as N-type calcium channel blockers.
    Doherty GA; Bhatia P; Vortherms TA; Marsh KC; Wetter JM; Mack H; Scott VE; Jarvis MF; Stewart AO
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1716-8. PubMed ID: 22277280
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ziconotide--a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain--a short review.
    Klotz U
    Int J Clin Pharmacol Ther; 2006 Oct; 44(10):478-83. PubMed ID: 17063978
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels.
    Yang ZQ; Barrow JC; Shipe WD; Schlegel KA; Shu Y; Yang FV; Lindsley CW; Rittle KE; Bock MG; Hartman GD; Uebele VN; Nuss CE; Fox SV; Kraus RL; Doran SM; Connolly TM; Tang C; Ballard JE; Kuo Y; Adarayan ED; Prueksaritanont T; Zrada MM; Marino MJ; Graufelds VK; DiLella AG; Reynolds IJ; Vargas HM; Bunting PB; Woltmann RF; Magee MM; Koblan KS; Renger JJ
    J Med Chem; 2008 Oct; 51(20):6471-7. PubMed ID: 18817368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery of novel neuronal voltage-dependent calcium channel blockers based on emopamil left hand as a bioactive template.
    Suzuki Y; Yamamoto N; Iimura Y; Kawano K; Kimura T; Nagato S; Ito K; Komatsu M; Norimine Y; Kimura M; Teramoto T; Kaneda Y; Hamano T; Niidome T; Yonaga M
    Bioorg Med Chem Lett; 2003 Mar; 13(5):919-22. PubMed ID: 12617921
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel T-type calcium channel blockers: dioxoquinazoline carboxamide derivatives.
    Jo MN; Seo HJ; Kim Y; Seo SH; Rhim H; Cho YS; Cha JH; Koh HY; Choo H; Pae AN
    Bioorg Med Chem; 2007 Jan; 15(1):365-73. PubMed ID: 17035033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel series of pyrazolylpiperidine N-type calcium channel blockers.
    Subasinghe NL; Wall MJ; Winters MP; Qin N; Lubin ML; Finley MF; Brandt MR; Neeper MP; Schneider CR; Colburn RW; Flores CM; Sui Z
    Bioorg Med Chem Lett; 2012 Jun; 22(12):4080-3. PubMed ID: 22608964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.